Vivendi (EPA:VIV) has been given a €30.00 ($35.71) price objective by research analysts at Goldman Sachs Group in a research report issued on Monday. The brokerage presently has a “buy” rating on the stock. Goldman Sachs Group’s price target would suggest a potential upside of 25.84% from the stock’s previous close.
VIV has been the subject of a number of other research reports. UBS Group set a €23.00 ($27.38) price objective on shares of Vivendi and gave the company a “buy” rating in a report on Friday, November 17th. Barclays set a €20.50 ($24.40) price objective on shares of Vivendi and gave the company a “neutral” rating in a report on Wednesday, October 4th. Credit Suisse Group set a €26.40 ($31.43) target price on shares of Vivendi and gave the company a “buy” rating in a research report on Friday. set a €24.00 ($28.57) target price on shares of Vivendi and gave the company a “buy” rating in a research report on Tuesday, October 24th. Finally, S&P Global set a €24.00 ($28.57) target price on shares of Vivendi and gave the company a “buy” rating in a research report on Friday, November 17th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and eight have assigned a buy rating to the company’s stock. Vivendi currently has a consensus rating of “Hold” and an average price target of €23.16 ($27.57).
Shares of Vivendi (EPA VIV) opened at €23.84 ($28.38) on Monday. Vivendi has a 1-year low of €15.96 ($19.00) and a 1-year high of €24.87 ($29.61). The stock has a market cap of $30,860.00 and a PE ratio of 68.11.
Vivendi SA is a France-based company engaged in media and content businesses. It operates businesses throughout the media value chain, from talent discovery to the creation, production and distribution of content. It operates through several segments. Its Universal Music Group segment is engaged in the sale of recorded music, exploitation of music publishing rights, as well as artist services and merchandising.
Receive News & Ratings for Vivendi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivendi and related companies with MarketBeat.com's FREE daily email newsletter.